Ocular Oncology and Pathology Subspecialty Day 2014: Saving Eyes and Saving Lives
In conjunction with the American Association of Ophthalmic Oncologists and Pathologists
Date: Saturday, Oct. 18
Time: 8 a.m. to 5:15 p.m.
Location: E350, McCormick Place, Chicago
Registration Now Open
Registration for the Ocular Oncology and Pathology Subspecialty meeting allows you to:
- Visit the AAO 2014 Exhibition on Saturday, Oct. 18.
- Float among all Subspecialty Day meetings held on Saturday, Oct. 18 – Cornea, Glaucoma, Oculofacial Plastic Surgery, Ocular Oncology and Pathology, Pediatric Ophthalmology, Refractive Surgery, Retina and Uveitis.
Hotel Reservations Now Open
Ocular Oncology and Pathology Program
Hans E. Grossniklaus, MD; Arun D. Singh, MD
The 2014 Ocular Oncology and Pathology Subspecialty Day aims to provide a comprehensive and focused review of state-of-the-art diagnostic and treatment procedures for retinoblastoma, melanoma, other intraocular tumors, conjunctival tumors, eyelid tumor and orbital tumors. These include currently available pathologic and molecular biologic diagnostic techniques, radiation therapy treatments, local and systemic chemotherapies, intra-arterial therapy, and emerging nanotechnology based therapies for ocular tumors. Information in this meeting can be applied to patients seen in most ophthalmology practices, such as conjunctival tumors in corneal practices, retinal/uveal tumors in retina practices, and eyelid/orbital tumors in comprehensive practices.
The intended target audience for this program is practicing ophthalmologists, residents in training and fellows.
The goal of this program is to provide attendees with a comprehensive and focused review of state-of-the-art diagnostic and treatment procedures for retinoblastoma, melanoma, other intraocular tumors, conjunctival tumors, eyelid tumor and orbital tumors.
Upon completion of this activity, participants should be able to:
- Identify clinical and pathologic features of ocular melanoma, retinoblastoma, conjunctival tumors and orbital tumors.
- Apply basic surgical and chemotherapeutic techniques to treat simple conjunctival and eyelid tumors.
- Recognize when to appropriately refer patients to an ocular oncology center.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.